Tenet Healthcare

Tenet Healthcare Corp. engages in the provision of health care services. It operates through the following segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment consists of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Tenet Healthcare reports robust Q4 earnings, eyes growth opportunities

Tenet Healthcare's Q4 2022 performance showcased strong financial results, effective cash flow management, and positive growth projections for 2023.
While facing challenges such as cyber attacks and COVID-related disruptions, the company is focused on addressing contract labor costs and driving growth.
Opportunities for Tenet Healthcare include organic growth, strategic acquisitions, and enhancing operational efficiencies to drive future success.
Overall, Tenet Healthcare's performance, strengths, challenges, and opportunities position the company for continued growth and financial stability.

Tenet Healthcare excels in Q1 2023, eyes growth opportunities

Tenet Healthcare's Q1 2023 performance was robust, driven by strong results in USPI and the hospital segment.
Challenges include deferred procedures in certain healthcare services and managing labor shortages, but opportunities exist in ortho procedure growth and improved contract labor rates.
The company's focus on efficiency and partnership benefits bode well for future growth and margin improvement.

Tenet Healthcare reports robust Q2 earnings, raises full-year guidance

Tenet Healthcare's Q2 2023 performance reflects strong financial results across segments, with raised EBITDA guidance and solid cash flow generation.
While facing challenges in specific markets and increased CapEx, the company remains focused on sustaining profitability and enhancing shareholder value.
Opportunities lie in continued growth prospects, strategic investments, and operational improvements to drive long-term success and market expansion.
Overall, Tenet Healthcare's performance highlights resilience, strategic focus, and commitment to delivering value to shareholders amidst evolving market dynamics.

Tenet Healthcare excels in Q3, eyes growth in USPI specialties

Tenet Healthcare's Q3 2023 performance showcased strong financial results across its segments, with a focus on high acuity services and cost control.
While facing challenges such as rising medical fee costs and clinical denials, Tenet is strategically positioned to capitalize on growth opportunities in USPI specialties and margin expansion.
The company's emphasis on technology investments, labor optimization, and strategic decision-making underscores its commitment to sustainable growth and operational efficiency.
With an upwardly revised guidance for 2023 and plans for 2024 formulation, Tenet Healthcare is poised for continued success through prudent financial management and strategic initiatives.

Tenet Healthcare posts robust Q4 earnings, eyes growth opportunities

Tenet Healthcare delivered strong financial results in Q4 2023, with solid EBITDA figures across its segments and a positive outlook for 2024. While facing challenges such as regulatory impacts and labor management, the company remains focused on capital allocation priorities and growth opportunities in high acuity services and ASC diversification.

Tenet Healthcare excels in Q1 2024, eyes growth opportunities

Tenet Healthcare's Q1 2024 performance showcased strong financial results, with notable growth in adjusted EBITDA across segments and successful deleveraging.
The company's strategic initiatives, including divestitures, acquisitions, and focus on revenue optimization, position it well for future growth and profitability.
Despite challenges like margin dilution from recent acquisitions and calendar effects, Tenet's focus on enhancing operational efficiency and seizing growth opportunities remains key.

Tenet Healthcare excels in Q2, eyes growth through efficiency

Tenet Healthcare's Q2 2024 earnings call reflects strong financial performance, strategic initiatives, and a positive outlook for the full year, underpinned by revenue growth and operational enhancements.
While facing challenges in margin management and revenue mix sustainability, Tenet's focus on efficiency, debt reduction, and shareholder value creation positions it well for future growth.
The company's emphasis on operational efficiency, capacity utilization, and strategic investments underscores its commitment to delivering quality care, driving performance, and seizing growth opportunities.

Tenet Healthcare excels in Q3, eyes strategic growth opportunities

Tenet Healthcare's Q3 2024 performance reflects robust revenue growth, margin expansion, and increased guidance, underpinned by strong cash generation and strategic financial management.
While facing challenges in forecasting and capital allocation, Tenet's focus on operational efficiency and shareholder value creation positions it well for future growth and resilience.
By capitalizing on opportunities for strategic investments, debt optimization, and prudent capital deployment, Tenet can navigate industry complexities and drive sustainable value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the Hospital Operations and Other, and Ambulatory Care segments. The Hospital Operations and Other segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The company was founded in 1969 and is headquartered in Dallas, TX.

Earnings Preview: What To Expect From Tenet Healthcare On Tuesday.

Earnings Preview: What To Expect From Tenet Healthcare On Tuesday

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced that Audrey Andrews, Executive Vice President and General Counsel, will retire from the Company at the end of the year. With this change, Tom Arnst, who currently oversees Human Resources for all three Company divisions as Executive Vice President and Chief Administrative Officer, will add the responsibility and reporting of the Tenet Enterprise legal department as General Counsel. Arnst's background as Chief Admi

Tenet Announces Executive Changes

FRISCO, Texas--(BUSINESS WIRE)--Conifer Health Solutions, a subsidiary of Tenet Healthcare Corporation (NYSE: THC), announced today the appointment of Muthu Krishnan as chief technology officer, effective April 26. Krishnan will lead the enterprise to align its solution architecture, technology platform and internal information technology services with the company's strategic vision. He will be responsible for driving enterprise-wide technology innovation while working closely with the chief in

Conifer Health Names Chief Technology Officer

Economic re-opening is well underway but the market appears to be developing some complacency.

Tenet Healthcare: Bullish Inklings Ahead Of Q1 Earnings Release

First Trust NASDAQ Global Auto Index Fund

Chevron

Hertz

iShares U.S. Healthcare Providers ETF

Jack in the Box

United States Gasoline Fund LP

Consumer Staples Select Sector SPDR Fund

Annual consumer price inflation rate in the United States rose to 2.6% in March 2021 from 1.7% in the previous month. This marked the highest rate since August 2018.

U.S. Inflation Hits More Than 2-Year High: ETFs & Stocks to Win

Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Tenet Healthcare (THC) to Report a Decline in Earnings: What to Look Out for

Community Health Systems

Both Tenet Healthcare (THC) and Community Health (CYH) are poised to grow in the thriving hospital industry. On comparative evaluation, we try to discover which stock has better chances of prosperity.

THC Pitted Against CYH: Which is a Better-Positioned Stock?

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced that it has formed a new committee of its Board of Directors focused on matters directly related to ESG (Environmental, Social and Governance). Richard Fisher, former President and CEO, Federal Reserve Bank of Dallas, serves as Committee Chair, and he is joined by the following Committee members: Meghan M. FitzGerald, DrPH, Adjunct Associate Professor, Columbia University; Richard Mark, Chairman and President, Ame

Tenet Forms New Board Committee Focused on ESG

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) plans to report results for its first quarter ending March 31, 2021 after the market closes on Tuesday, April 20, 2021. The company will host a conference call the following morning, Wednesday, April 21, 2021, at 10:00 a.m. Eastern time (9:00 a.m. Central time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healt

Tenet to Report its First Quarter 2021 Results on April 20

Tenet Healthcare's (THC) shares display an upsurge as investors get optimistic about its latest strategic initiatives and cost-curbing measures.

Tenet Healthcare (THC) Hits 52 Week High: Will the Rally Stay?

In the latest trading session, Tenet Healthcare (THC) closed at $55.62, marking a +0.07% move from the previous day.

Tenet Healthcare (THC) Gains But Lags Market: What You Should Know

Is (THC) Outperforming Other Medical Stocks This Year?

Is Tenet Healthcare (THC) Outperforming Other Medical Stocks This Year?

Tenet Healthcare's (THC) unit Conifer extends alliance with NorthShore till 2024 with an aim to offer enhanced revenue cycle services to NorthShore.

Tenet Healthcare (THC) Unit Extends Services to NorthShore

FRISCO, Texas--(BUSINESS WIRE)--Conifer Health Solutions, a subsidiary of Tenet Healthcare Corporation (NYSE: THC), announced today a multi-year contract extension with NorthShore University HealthSystem (NorthShore). Building on a relationship of more than 20 years, Conifer will continue to provide physician revenue cycle services to NorthShore through 2024. Conifer's comprehensive accounts receivable (AR) services, coupled with enhanced revenue cycle performance insights, equips NorthShore wi

Conifer Health Announces Multi-Year Contract Extension with NorthShore University HealthSystem

Anthem

Bausch Health Companies Inc

DuPont de Nemours

Norfolk Southern

Takeda Pharmaceutical

Glenview Capital Management recently disclosed its portfolio updates for the fourth quarter of 2020, which ended on Dec. 31.

The Top New Buys of Larry Robbins' Firm

Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Tenet (THC) Hits 52-Week High, Can the Run Continue?

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the Raymond James Institutional Investors Conference on Tuesday, March 2, 2021, beginning at 9:10 a.m. Eastern time. A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare s

Tenet to Participate in Raymond James Institutional Investors Conference

FRISCO, Texas--(BUSINESS WIRE)--Conifer Health Solutions, a subsidiary of Tenet Healthcare Corporation (NYSE: THC), announced today the expansion of its relationship with LCMC Health to provide physician accounts receivable (AR) management small-balance support and COVID-19 vaccine scheduling services. Conifer currently provides eligibility and enrollment services (EES) and patient financial counseling to five of the health system's hospitals in the greater New Orleans area. “Conifer has proven

Conifer Health Expands Business Partnership With LCMC Health

HCA Healthcare

These hospital stocks have done relatively well despite the challenges presented by the pandemic and are set to gain handsomely this year The post 3 Hospital Stocks to Watch As the Pandemic Drags On appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next Potential Winner It doesn't matter if you have $500 in savings or $5 million.

3 Hospital Stocks to Watch As the Pandemic Drags On

Acadia Healthcare

Universal Health Services

4 Hospital Stocks to Gain From Growth in Patient Admissions

Tenet Healthcare Corporation (THC) CEO Ron Rittenmeyer on Q4 2020 Results - Earnings Call Transcript

Tenet Healthcare's (THC) Q4 earnings improve on the back of better revenues.

Tenet Healthcare (THC) Q4 Earnings Beat Estimates, Rise Y/Y

NEW YORK, Feb. 10, 2021 /PRNewswire/ -- Glenview Capital Management ("Glenview"), the largest shareholder of Tenet Healthcare Corporation ("Tenet" or the "Company") (NYSE:THC), today announced that it confirms its support of the Board's decision to spin-off the Company's Conifer...

Tenet Healthcare 15% Shareholder Glenview Capital Issues Letter of Support for Spin-Off of Conifer by Mid 2022

The hospital operator delivered another strong performance despite facing headwinds related to the COVID-19 pandemic.

Here's What to Like About Tenet Healthcare's Q4 Results

Shares of Tenet Healthcare (NYSE:THC) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 376.77% over the past year to $4.72, which beat the estimate of $1.70.

News for Tenet Healthcare Stock (THC)